A shot every three months helps cats move better, a win for arthritis in pets
☕ Includes a question for the family ↓
Arthritis in dogs and catsPart of a story we are following · 2 articles · See every update
If your older cat has stopped leaping onto the couch, there is good news for arthritis in pets. A new shot, given just once every three months, helped most cats with arthritis feel and move better in a large trial.
The shot is called relfovetmab. Owners saw real improvement in their cats’ daily activities, and some saw it within days. For a cat that hates car rides and carriers, four shots a year is a lot easier than a daily pill.
How the study worked
Researchers followed 307 pet cats with arthritis, with a median age of 11.0 years, at several veterinary clinics. By chance, half got relfovetmab and half got a saltwater placebo, as an injection under the skin every three months for three doses. Neither the owners nor the vets knew which cat got which. The trial ran nine months and was published Oct. 2, 2026, in The Veterinary Journal. Owners did most of the judging, since they know best how their own cat behaves at home.
What they found
Success meant that owners saw a clear improvement in the activities that were hardest for their cat. At day 90, that happened for 73.0% of cats who got relfovetmab. For cats who got the placebo, it was 46.8%. That means most treated cats got better, and clearly more of them than with the fake shot.
| Any side effect, relfovetmab | 44.4% |
|---|---|
| Any side effect, placebo | 39.6% |
| Pain at injection, relfovetmab | 7.2% |
| Pain at injection, placebo | 1.3% |
The benefit showed up early, as soon as three days after the first dose. It held through the whole nine months. Owners also rated their cats higher on quality of life, temperament and happiness, and the vets’ own pain checks pointed the same way.
Safety looked good too. Side effects of any kind were about as common in both groups: 44.4% with relfovetmab and 39.6% with placebo. The one difference was pain at the injection spot, which happened in 7.2% of treated cats and 1.3% of placebo cats. A cat’s body made antibodies against the drug in only 3 cats (1.97%). It was temporary and did not affect safety.
Why cats hide arthritis
Arthritis is very common in older cats, but it often goes unnoticed. Cats hide pain. The signs are easy to mistake for normal aging: jumping less, sleeping more, skipping grooming, or seeming grumpy when touched.
The shot works differently from many pain medicines. It is an antibody, a protein made to block nerve growth factor. That is one of the body’s pain signals. Blocking it turns down the pain at its source.
What you can do today
Take five minutes and watch your older cat jump. Encourage it to hop onto a couch or chair a few times, and notice whether it hesitates, jumps shorter or skips it. Jot down what you see, along with any changes in grooming, sleep or litter box habits. That note is exactly what your vet needs to check for arthritis and talk about pain treatment.
Talk about it at home
Cats are very good at hiding when something hurts. Scientists tested a medicine by giving some cats the real shot and others a fake one, and nobody knew who got which until the end. That way they could tell whether the medicine really made the difference.
Question for the table
Here is a question for the table: why do you think the scientists gave some cats a fake shot instead of giving every cat the real one?
Keep exploring
Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.
Questions and answers
- What is relfovetmab?
- It is an antibody for cats that blocks nerve growth factor, a pain signal. It is given as a shot under the skin every three months.
- How well did it work?
- At day 90, 73.0% of treated cats had treatment success, compared with 46.8% of cats given a placebo.
- How fast did it start working?
- Benefits showed up as early as three days after the first dose and lasted through the nine-month study.
- Was it safe?
- Side effects were about as common as with placebo. The one difference was pain at the injection spot, 7.2% vs. 1.3%.
